DK2827860T3 - Anvendelse af a pyrazol-derivat i behandlingen af akutte forværringer af kronisk obstruktiv lungesygdom - Google Patents
Anvendelse af a pyrazol-derivat i behandlingen af akutte forværringer af kronisk obstruktiv lungesygdom Download PDFInfo
- Publication number
- DK2827860T3 DK2827860T3 DK13710851.0T DK13710851T DK2827860T3 DK 2827860 T3 DK2827860 T3 DK 2827860T3 DK 13710851 T DK13710851 T DK 13710851T DK 2827860 T3 DK2827860 T3 DK 2827860T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- obstructive pulmonary
- methylbenzamide
- cyclopropyl
- pulmonary disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Claims (9)
1. 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-l-yl]-N-cycloprc>pyl-4-methylbenzamid eller et farmaceutisk acceptabelt salt, hydrat eller solvat deraf til anvendelse i behandlingen af akutte forværringer af kronisk obstruktiv lungesygdom.
2. Enkelt dosis af 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-l-yl]-N-cyclopropyl-4-methylbenzamid eller et farmaceutisk acceptabelt salt, hydrat eller solvat deraf til anvendelse i behandlingen af akutte forværringer af kronisk obstruktiv lungesygdom.
3. Oral farmaceutisk sammensætning der indeholder 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-l-yl]-N-cyclopropyl-4-methylbenzamid eller et farmaceutisk acceptabelt salt, hydrat eller solvat deraf til anvendelse i behandlingen af akutte forværringer af kronisk obstruktiv lungesygdom.
4. Farmaceutisk sammensætning til anvendelse ifølge krav 3 der indeholder 50 til 100 mg af 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-l-yl]-N-cyclopropyl-4-methylbenzamid eller et farmaceutisk acceptabelt salt, hydrat eller solvat deraf.
5. Farmaceutisk sammensætning til anvendelse ifølge krav 4 der indeholder 60 til 90 mg af 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-l-yl]-N-cyclopropyl-4-methylbenzamid eller et farmaceutisk acceptabelt salt, hydrat eller solvat deraf.
6. Farmaceutisk sammensætning til anvendelse ifølge krav 5 der indeholder 75 mg af 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-l-yl]-N-cyclopropyl-4-methylbenzamid eller et farmaceutisk acceptabelt salt, hydrat eller solvat deraf.
7. Farmaceutisk sammensætning til anvendelse ifølge krav 6 der indeholder 75 mg af 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-l-yl]-N-cyclopropyl-4-methylbenzamid i sin frie form.
8. Farmaceutisk sammensætning til anvendelse ifølge krav 3 i form af en tablet.
9. Farmaceutisk sammensætning til anvendelse ifølge krav 7 i form af en tablet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261613187P | 2012-03-20 | 2012-03-20 | |
PCT/EP2013/055730 WO2013139809A1 (en) | 2012-03-20 | 2013-03-19 | Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2827860T3 true DK2827860T3 (da) | 2016-12-12 |
Family
ID=47901996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13710851.0T DK2827860T3 (da) | 2012-03-20 | 2013-03-19 | Anvendelse af a pyrazol-derivat i behandlingen af akutte forværringer af kronisk obstruktiv lungesygdom |
Country Status (30)
Country | Link |
---|---|
US (2) | US9339491B2 (da) |
EP (1) | EP2827860B1 (da) |
JP (1) | JP6091593B2 (da) |
KR (1) | KR101793777B1 (da) |
CN (1) | CN104203234B (da) |
AU (1) | AU2013237503B2 (da) |
BR (1) | BR112014023107B1 (da) |
CA (1) | CA2866108C (da) |
CL (1) | CL2014002471A1 (da) |
CY (1) | CY1118327T1 (da) |
DK (1) | DK2827860T3 (da) |
ES (1) | ES2605942T3 (da) |
HK (1) | HK1200352A1 (da) |
HR (1) | HRP20161514T1 (da) |
HU (1) | HUE032004T2 (da) |
IL (1) | IL234537A (da) |
LT (1) | LT2827860T (da) |
MA (1) | MA37455B1 (da) |
MX (1) | MX351996B (da) |
NZ (1) | NZ628392A (da) |
PH (1) | PH12014502107B1 (da) |
PL (1) | PL2827860T3 (da) |
PT (1) | PT2827860T (da) |
RU (1) | RU2625762C2 (da) |
SG (1) | SG11201404941WA (da) |
SI (1) | SI2827860T1 (da) |
TN (1) | TN2014000350A1 (da) |
TW (1) | TWI583381B (da) |
WO (1) | WO2013139809A1 (da) |
ZA (1) | ZA201405871B (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2600822C1 (ru) * | 2015-09-03 | 2016-10-27 | ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ (ФГБУ "РНЦРХТ" Минздрава России) | Способ лечения хронического обструктивного бронхита |
RU2600833C1 (ru) * | 2015-09-03 | 2016-10-27 | ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ (ФГБУ "РНЦРХТ" Минздрава России) | Способ лечения хронической обструктивной болезни легких |
WO2017153701A1 (en) * | 2016-03-08 | 2017-09-14 | Mereo Biopharma 1 Limited | Dosage regimen for the treatment of acute exacerbations of inflammatory conditions |
CA3016488C (en) * | 2016-03-08 | 2023-04-11 | Mereo Biopharma 1 Limited | Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease |
US10331542B2 (en) * | 2016-06-23 | 2019-06-25 | International Business Machines Corporation | System and method for detecting and alerting unexpected behavior of software applications |
GB201612238D0 (en) * | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-Yl]-n-cyclopropyl-4-methylbenzamide |
GB201612240D0 (en) | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
CA3128468A1 (en) | 2017-10-05 | 2019-04-11 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd |
EP3585383B1 (en) | 2017-12-11 | 2021-03-24 | Mereo BioPharma 1 Limited | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease |
ES2884789T3 (es) | 2017-12-11 | 2021-12-13 | Mereo Biopharma 1 Ltd | Uso de 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-N-ciclopropil-4-metilbenzamida en el tratamiento de exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA05013824A (es) * | 2003-06-26 | 2006-02-28 | Novartis Ag | Inhibidores de quinasa p38 basados en heterociclos de 5 miembros. |
GB0603684D0 (en) * | 2006-02-23 | 2006-04-05 | Novartis Ag | Organic compounds |
-
2013
- 2013-03-19 BR BR112014023107-9A patent/BR112014023107B1/pt active IP Right Grant
- 2013-03-19 AU AU2013237503A patent/AU2013237503B2/en active Active
- 2013-03-19 LT LTEP13710851.0T patent/LT2827860T/lt unknown
- 2013-03-19 CN CN201380015703.5A patent/CN104203234B/zh active Active
- 2013-03-19 MA MA37455A patent/MA37455B1/fr unknown
- 2013-03-19 PT PT137108510T patent/PT2827860T/pt unknown
- 2013-03-19 KR KR1020147025904A patent/KR101793777B1/ko active IP Right Grant
- 2013-03-19 ES ES13710851.0T patent/ES2605942T3/es active Active
- 2013-03-19 SG SG11201404941WA patent/SG11201404941WA/en unknown
- 2013-03-19 SI SI201330397A patent/SI2827860T1/sl unknown
- 2013-03-19 PL PL13710851T patent/PL2827860T3/pl unknown
- 2013-03-19 RU RU2014141893A patent/RU2625762C2/ru active
- 2013-03-19 US US14/386,174 patent/US9339491B2/en active Active
- 2013-03-19 JP JP2015500892A patent/JP6091593B2/ja active Active
- 2013-03-19 HU HUE13710851A patent/HUE032004T2/en unknown
- 2013-03-19 CA CA2866108A patent/CA2866108C/en active Active
- 2013-03-19 EP EP13710851.0A patent/EP2827860B1/en active Active
- 2013-03-19 TW TW102109739A patent/TWI583381B/zh active
- 2013-03-19 NZ NZ628392A patent/NZ628392A/en unknown
- 2013-03-19 WO PCT/EP2013/055730 patent/WO2013139809A1/en active Application Filing
- 2013-03-19 DK DK13710851.0T patent/DK2827860T3/da active
- 2013-03-19 MX MX2014011291A patent/MX351996B/es active IP Right Grant
-
2014
- 2014-08-11 TN TNP2014000350A patent/TN2014000350A1/fr unknown
- 2014-08-11 ZA ZA2014/05871A patent/ZA201405871B/en unknown
- 2014-09-08 IL IL234537A patent/IL234537A/en active IP Right Grant
- 2014-09-17 CL CL2014002471A patent/CL2014002471A1/es unknown
- 2014-09-22 PH PH12014502107A patent/PH12014502107B1/en unknown
-
2015
- 2015-01-29 HK HK15101000.9A patent/HK1200352A1/zh unknown
-
2016
- 2016-04-29 US US15/143,356 patent/US20160243081A1/en not_active Abandoned
- 2016-11-16 HR HRP20161514TT patent/HRP20161514T1/hr unknown
- 2016-11-18 CY CY20161101194T patent/CY1118327T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2827860T3 (da) | Anvendelse af a pyrazol-derivat i behandlingen af akutte forværringer af kronisk obstruktiv lungesygdom | |
EP3495362B1 (en) | Imidazopyridine thioglycolic acid derivative, preparation method therefor and application thereof | |
US20190015401A1 (en) | Deuterated analogs of pridopidine useful as dopaminergic stabilizers | |
JP2005511722A6 (ja) | Birb796bsの投与方法 | |
KR20150046110A (ko) | 피르페니돈 치료제의 투여 방법 | |
Joos et al. | Bronchodilatory effects of aclidinium bromide, a long-acting muscarinic antagonist, in COPD patients | |
JP2020521726A (ja) | Pde9阻害剤を含む医薬組成物 | |
JP2011518168A5 (da) | ||
KR20240009918A (ko) | 바이러스 감염 치료를 위한 rock2 억제제 | |
EP2694074B1 (en) | Use of a2b adenosine receptor antagonists for treating heart failure and arrhythmia in post-myocardial infarction patients | |
EP2865680A1 (en) | Xanthine derivative | |
ES2249488T3 (es) | Moduladores de canales de sodio derivados de 2-piperidilimidazoles. | |
Chauhan et al. | Combination therapeutic approach for asthma and allergic rhinitis | |
US20170029389A1 (en) | Pain-related compound and medical composition | |
WO2023056463A1 (en) | Glycogen synthase kinase 3 (gsk3) inhibitors for treating ctnnb1 syndrome | |
WO2021092053A1 (en) | Mcl-1 inhibitor macrocycle compounds for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer | |
DE102020125641A1 (de) | Wirkstoffe und Arzneimittel für die Therapie von Viruserkrankungen, insbesondere Corona-Infektionen, insbesondere COVID-19 | |
WO2012070601A1 (ja) | 新規な2-アルキニル-n9-プロパギルアデニンおよびその医薬用途 | |
Fessenmeyer et al. | Prognosis value of ECG abnormalities, myocardial specific enzymes and cardiac function in spontaneous subarachnoid hemorrhage: A-533 |